4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000014
Chief Scientific Officer gave up 1,058 shares (to pay taxes)
- Chief Scientific Officer acquired 28,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sethuraman Natarajan · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-01 | Grant or award : show line 1 in the form | +28,400 | 190,544 | D | ||
| 2023-03-02 | Shares withheld for taxes : show line 2 in the form | −1,058 | $11.60 | $12,269 | 189,486 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +43,000 | 43,000 | D |
Loading xslF345X03/wf-form4_167787931361377.xml…